HGWM
RXDX

Harvest Group Wealth Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Harvest Group Wealth Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$859 Hold
8
– – ﹤0.01% 155
2022
Q4 		$880 Hold
8
– – ﹤0.01% 150
2022
Q3 		$0 Sell
8
-5
-38% -$229 ﹤0.01% 208
2022
Q2 		$1K Buy
+13
New +$377 ﹤0.01% 172

Other funds holding RXDX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Harvest Group Wealth Management's RXDX Position: Q1 2023 in Review

Harvest Group Wealth Management held its Prometheus Biosciences, Inc. Common Stock (RXDX) position steady in Q1 2023 at 8 shares worth $859. The position accounts for ﹤0.01% of the portfolio, ranked #155.

Harvest Group Wealth Management first reported a position in RXDX in Q2 2022 and has held it in 4 quarters since. The position peaked at $1K in Q2 2022. 219 funds tracked by Wall St. Rank hold RXDX as of Q1 2023.

  • Harvest Group Wealth Management held 8 shares of Prometheus Biosciences, Inc. Common Stock worth $859 as of Q1 2023.
  • Harvest Group Wealth Management left its Prometheus Biosciences, Inc. Common Stock share count unchanged in Q1 2023.
  • Prometheus Biosciences, Inc. Common Stock made up ﹤0.01% of Harvest Group Wealth Management's portfolio in Q1 2023, its #155 holding.
  • Harvest Group Wealth Management first reported a position in Prometheus Biosciences, Inc. Common Stock in Q2 2022 and has held it in 4 quarters since.
  • Harvest Group Wealth Management's Prometheus Biosciences, Inc. Common Stock position peaked at $1K in Q2 2022.
  • 219 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q1 2023.

Based on Harvest Group Wealth Management's 13F filing for Q1 2023, filed 28 Apr 2023.